StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)

Close on Nov 18, 2026Market cap $1.98MP/E –Yield –

Can-Fite BioPharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$8.95M. The highest annual figure on record is -$4.19M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.95M–
FY2024Dec 31, 2024-$7.64M–
FY2023Dec 31, 2023-$8.44M–
FY2022Dec 31, 2022-$10.81M–
FY2021Dec 31, 2021-$9.87M–
FY2020Dec 31, 2020-$12.09M–
FY2019Dec 31, 2019-$11.09M–
FY2018Dec 31, 2018-$4.19M–
FY2017Dec 31, 2017-$8.98M–
FY2016Dec 31, 2016-$8.72M–
FY2015Dec 31, 2015-$4.86M–

More Can-Fite BioPharma figures

See a number that looks wrong?